高同型半胱氨酸血症与健康体检人群的低高密度脂蛋白血症有关
作者:
作者单位:

(首都医科大学附属北京朝阳医院内分泌科,北京市 100020)

作者简介:

刘佳,博士,主治医师,研究方向为同型半胱氨酸及动脉粥样硬化,E-mail为liujia0116@126.com。

基金项目:

国家自然科学基金(81270369、81070244、30770873);北京市自然科学基金(7142060);中国糖尿病英才基金(YC2014-CYLJ);北京市重点实验室基金(1300-1150170642)


Hyperhomocysteinemia Is Related to the Low Level of High Density Lipoprotein in Healthy People
Author:
Affiliation:

Department of Endocrinology, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing 100020, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的 观察高同型半胱氨酸血症(Hhcy)对健康体检人群血高密度脂蛋白(HDL)及载脂蛋白AⅠ(ApoAⅠ)水平的影响。方法 选取无高血压、糖尿病等疾病的健康体检人群,共1980名。根据是否合并HHcy分成两组:HHcy组及对照组。测定空腹血糖、空腹胰岛素、血脂等生物化学指标,并测定ApoAⅠ水平及计算稳态模型胰岛素抵抗指数。结果 HHcy组血高密度脂蛋白胆固醇(HDLC)、ApoAⅠ水平显著低于对照组(1.16±0.25 mmol/L比1.27±0.31 mmol/L,1.37±0.19 g/L比1.46±0.26 g/L,均P<0.01)。相关分析显示,在校正了年龄、体质指数及甘油三酯水平后,血同型半胱氨酸(Hcy)水平与HDLC、ApoAⅠ呈明显负相关(r=-0.10,r=-0.11,P<0.05)。多元回归分析显示,血Hcy水平是血ApoAⅠ的独立影响因子(β=-0.067,P<0.05)。结论 HHcy与低HDL血症有关。HHcy可能通过降低HDL、ApoAⅠ水平导致健康人群发生动脉粥样硬化。临床上应积极治疗HHcy。

    Abstract:

    Aim To investigate the effect of hyperhomocysteinemia (Hhcy) on serum high density lipoprotein (HDL) and apolipoprotein AⅠ (ApoAⅠ) in healthy people. Methods A total of 1980 normal healthy people was recruited without hypertension, diabetes and other diseases. According to whether the HHcy, the subjects were divided into two groups:HHcy group and control group. Biochemical parameters such as fasting blood glucose, fasting insulin and blood lipid were measured. ApoAⅠ was measured and the homeostasis model assessment index of insulin resistance was calculated. Results The level of serum high density lipoprotein cholesterol (HDLC) and ApoAⅠ in HHcy group was significantly lower than that in control group (1.16±0.25 mmol/L vs 1.27±0.31 mmol/L, 1.37±0.19 g/L vs 1.46±0.26 g/L, all P<0.01). Correlation analysis showed that after adjusting for age, body mass index and triglyceride levels, blood homocysteine (Hcy) level was significantly negatively correlated with HDLC and ApoAⅠ (r=-0.10, r=-0.11, P<0.05). Multiple regression analysis showed that the blood Hcy level was the independent influencing factor of blood ApoAⅠ (β=-0.067, P<0.05). Conclusions HHcy is associated with low HDL. HHcy may lead to atherosclerosis in healthy people by decreasing the levels of HDL and ApoAⅠ. Clinically, HHcy should be actively treated.

    参考文献
    [1] Wu Y, Huang Y, Hu Y, et al.Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China.Herz, 3,8(7):779-784.
    [2] Zaid M, Fujiyoshi A, Miura K, et al.High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men.Atherosclerosis, 5,9(2):444-450.
    [3] Umemoto T, Han CY, Mitra P, et al.Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters:ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.Circ Res, 3,2(10):1 345-354.
    [4] Mikael LG, Genest J Jr, Rozen R, et al.Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.Circ Res, 6,8(4):564-571.
    [5] Liu J, Wang Y, Fan H, et al.Hyperhomocysteinaemia is associated with low plasma apolipoprotein AI levels in patients with impaired glucose tolerance.Diab Vasc Dis Res, 5,2(4):298-301.
    [6] Matthews DR, Hosker JP, Rudenski AS, et al.Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia, 5,8(7):412-419.
    [7] Chmurzynska A, Malinowska AM, Twardowska-Rajewska J, et al.Elderly women:homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism).Nutrition, 3,9(6):841-844.
    [8] Liu J, Xu Y, Zhang H, et al.Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.J Hum Hypertens, 4,8(12):743-747.
    [9] Wang G, Dai J, Mao J, et al.Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia.Atherosclerosis, 5,9(2):395-402.
    [10] 蒋承建, 郭航远, 唐伟良, 等.同型半胱氨酸对内皮祖细胞生成eNOS、p-eNOS和NO的影响及黄酒的改善作用.中国动脉硬化杂志, 5,3(5):475-479.
    [11] 侯跃龙, 陆薇薇, 张金胜, 等.同型半胱氨酸通过内质网应激反应促进大鼠血管平滑肌细胞钙化.中国动脉硬化杂志, 5,3(5):437-442.
    [12] 郑卫峰, 王晓阳, 张守彦, 等.H型高血压与急性心肌梗死患者急诊经皮冠状动脉介入治疗术后发生慢血流的相关性.中国动脉硬化杂志, 5,3(10):1 035-038.
    [13] Rodrigo R, Passalacqua W, Araya J, et al.Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension.J Cardiovasc Pharmacol, 3,2(4):453-461.
    [14] Januszewicz A.High normal blood pressure--a problem of growing clinical importance.Kardiol Pol, 2,0(3):259.
    [15] Yoon NS, Jeong MH, Ahn Y, et al.Impact of high-normal blood pressure measured in emergency room on adverse cardiac events in acute myocardial infarction.Korean Circ J, 2,2(5):304-310.
    [16] Li Y, Zhang H, Jiang C, et al.Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue.J Biol Chem, 3,8(14):9 583-592.
    [17] Jiang C, Zhang H, Zhang W, et al.Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin.Am J Physiol Cell Physiol, 9,7(6):C1 466-476.
    [18] Tangvarasittichai S.Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.World J Diabetes, 5,6(3):456-480.
    [19] Dansky HM, Charlton SA, Barlow CB, et al.Apo AI inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium.J Clin Invest, 9,4(1):31-39.
    [20] Holven KB, Retterstol K, Ueland T, et al.Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.PLoS One, 3,8(11):e78 241.
    [21] Xiao Y, Zhang Y, Lv X, et al.Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects.Lipids Health Dis, 1,0(1):137.
    [22] Sood HS, Hunt MJ, Tyagi SC.Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.Am J Physiol Lung Cell Mol Physiol, 3,4(2):L333-L341.
    [23] Anselmino M, Sillano D.Impact of pre-diabetes and diabetes on cardiovascular outcomes.Curr Vasc Pharmacol, 2,0(6):680-683.
    [24] Morishima A, Ohkubo N, Maeda N, et al.NF kappa B regulates plasma apolipoprotein AI and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.J Biol Chem, 3,8(40):38 188-193.
    相似文献
    引证文献
引用本文

刘佳,胡延晋,潘永华,苗莉,陈哲,张恒,徐援,王广.高同型半胱氨酸血症与健康体检人群的低高密度脂蛋白血症有关[J].中国动脉硬化杂志,2016,24(8):803~806.

复制
分享
文章指标
  • 点击次数:1244
  • 下载次数: 1387
历史
  • 收稿日期:2015-11-10
  • 最后修改日期:2015-12-12
  • 在线发布日期: 2016-07-25